Article
Efficacy of parainfluenza virus 5 mutants expressing hemagglutinin from H5N1 influenza A virus in mice.
Journal of virology - 1 Sept 2013
Li Zhuo, Gabbard Jon D, Mooney Alaina, Chen Zhenhai, Tompkins S Mark, He Biao
Abstract excerpt
Parainfluenza virus 5 (PIV5) is a promising viral vector for vaccine development. PIV5 is safe, stable, efficacious, cost-effective to produce and, most interestingly, it overcomes preexisting antivector immunity. We have recently reported that PIV5 expressing the hemagglutinin (HA) from highly pathogenic avian influenza (HPAI) virus H5N1 (PIV5-H5) provides sterilizing immunity against lethal doses of HPAI H5N1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
